Prof Dawn Langdon
Royal Holloway, University of London, UK
(Previously Secretary 2012-7)
Professor of Neuropsychology and Director of Health and Medicine, Royal Holloway, University of London, UK
Dawn Langdon completed her training as a clinical psychologist at Oxford University and the Institute of Psychiatry, London. She worked as a clinical neuropsychologist at the National Hospital, Queen Square, London for sixteen years, obtaining a PhD on reasoning in organic brain syndromes and registration as both a neuropsychologist and a health psychologist.
She is now a Professor of Neuropsychology at Royal Holloway, University of London. She is neuropsychology lead on a number of multinational trials. Her research work centres on psychological aspects of MS and current projects include the efficacy of medication in protecting cognition, cognitive rehabilitation, cognitive profiles in CIS and early MS and cognition in the later stages of MS, including its relation to early disease status, and measuring and understanding motor planning. She is developing a protocol to optimise communication of drug information to people with MS (BRIMMS: Benefits and Risks of Medication in MS). She is co-chair of both the BICAMS initiative (www.BICAMS.net) and MS in the 21st Century.
She is a frequent contributor to international scientific meetings and committees and is a Trustee of the UK MS Trust, with whom she has authored the MS cognition website www.stayingsmart.org.uk.